Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Honey Reddi PhD

Honey Reddi PhD profile photo picture

Center Associate Director, Associate Professor

Institution: Medical College of Wisconsin
Department: Pathology
Division: Administration

Member of the Cardiovascular Center


I am willing to mentor a junior faculty member.
I am willing to collaborate on research projects.


Research Experience

  • Cohort Studies
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Models, Biological
  • Mutation
  • Oncolytic Viruses
  • Precision Medicine
  • Retrospective Studies
  • Thyroid Neoplasms
  • Clinical Expertise

  • Genetic Testing
  • High-Throughput Nucleotide Sequencing
  • Precision Medicine
  • Publications (52)

  • Addendum: Technical standards and guidelines for spinal muscular atrophy testing. (Deignan JL, Astbury C, Behlmann A, Guha S, Monaghan KG, Reddi HV, Seifert BA, Tayeh M, Wakeling E, ACMG Laboratory Quality Assurance Committee) Genet Med 2020 Oct 13 PMID: 33046848 10/14/2020    
  • CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence. (Zhao Y, Pan Z, Namburi S, Pattison A, Posner A, Balachander S, Paisie CA, Reddi HV, Rueter J, Gill AJ, Fox S, Raghav KPS, Flynn WF, Tothill RW, Li S, Karuturi RKM, George J) EBioMedicine 2020 Nov;61:103030 PMID: 33039710 PMCID: PMC7553237 SCOPUS ID: 2-s2.0-85092280035 10/12/2020       1 Citation
  • Novel CTNND2-TERT fusion in a spindle cell liposarcoma. (Occidental M, Shen G, Feng X, Zhu K, Kelly K, Nie Q, Reddi HV, Lakiotaki E, Viniou NA, Korkolopoulou P, Linos K, Jour G) Genes Chromosomes Cancer 2020 09;59(9):544-548 PMID: 32352179 SCOPUS ID: 2-s2.0-85085127685 05/01/2020    
  • Molecular profiling of gynecologic cancers for treatment and management of disease - demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and reporting of somatic variants. (Nie Q, Omerza G, Chandok H, Prego M, Hsiao MC, Meyers B, Hesse A, Uvalic J, Soucy M, Bergeron D, Peracchio M, Burns S, Kelly K, Rowe S, Rueter J, Reddi HV) Cancer Genet 2020 04;242:25-34 PMID: 31992506 SCOPUS ID: 2-s2.0-85078432890 01/30/2020    
  • Molecular profiling of CNS tumors for the treatment and management of disease. (Nie Q, Hsiao MC, Chandok H, Rowe S, Prego M, Meyers B, Omerza G, Hesse A, Uvalic J, Soucy M, Bergeron D, Peracchio M, Burns S, Kelly K, Rueter J, Reddi HV) J Clin Neurosci 2020 Jan;71:311-315 PMID: 31859178 SCOPUS ID: 2-s2.0-85076547272 12/21/2019    
  • Mutation Yield of a Custom 212-Gene Next-Generation Sequencing Panel for Solid Tumors: Clinical Experience of the First 260 Cases Tested Using the JAX ActionSeq™ Assay. (Selvam P, Hsiao MC, Omerza G, Bergeron D, Rowe S, Uvalic J, Soucy M, Peracchio M, Burns S, Meyers B, Prego M, Nie Q, Ananda G, Chandok H, Kelly K, Hesse A, Reddi HV) Mol Diagn Ther 2020 02;24(1):103-111 PMID: 31754995 SCOPUS ID: 2-s2.0-85076799256 11/23/2019       1 Citation
  • Functional interrogation of Lynch syndrome-associated MSH2 missense variants via CRISPR-Cas9 gene editing in human embryonic stem cells. (Rath A, Mishra A, Ferreira VD, Hu C, Omerza G, Kelly K, Hesse A, Reddi HV, Grady JP, Heinen CD) Hum Mutat 2019 11;40(11):2044-2056 PMID: 31237724 PMCID: PMC6810757 SCOPUS ID: 2-s2.0-85070793170 06/27/2019       5 Citations
  • Evaluating gene fusions in solid tumors - Clinical experience using an RNA based 53 gene next-generation sequencing panel. (Selvam P, Kelly K, Hesse AN, Spitzer D, Reddi HV) Cancer Genet 2019 04;233-234:32-42 PMID: 31109592 SCOPUS ID: 2-s2.0-85063351249 05/22/2019       2 Citations
  • Technical and Regulatory Considerations for Taking Liquid Biopsy to the Clinic: Validation of the JAX PlasmaMonitorTM Assay. (Sisson BA, Uvalic J, Kelly K, Selvam P, Hesse AN, Ananda G, Chandok H, Bergeron D, Holinka L, Reddi HV) Biomark Insights 2019;14:1177271919826545 PMID: 30745794 PMCID: PMC6360476 02/13/2019    
  • Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts. (Marlow LA, Rohl SD, Miller JL, Knauf JA, Fagin JA, Ryder M, Milosevic D, Netzel BC, Grebe SK, Reddi HV, Smallridge RC, Copland JA) J Clin Endocrinol Metab 2018 09 01;103(9):3169-3182 PMID: 29846633 PMCID: PMC6126888 SCOPUS ID: 2-s2.0-85054142148 05/31/2018       5 Citations
  • Retrospective genotype-phenotype analysis in a 305 patient cohort referred for testing of a targeted epilepsy panel. (Hesse AN, Bevilacqua J, Shankar K, Reddi HV) Epilepsy Res 2018 08;144:53-61 PMID: 29778030 SCOPUS ID: 2-s2.0-85046837515 05/20/2018       4 Citations
  • Genomic Profiling of Two Histologically Distinct Rare Urothelial Cancers in a Clinical Setting to Identify Potential Therapeutic Options for Treatment and Management of Disease. (Hesse AN, Fabricius W, Thomas CA, Gaindh R, Christman R, Selvam P, Prego M, Lewis G, Uvalic J, Bergeron D, Burns S, Sisson B, Kelly K, Rueter J, Reddi HV) Case Rep Oncol 2018 Jan-Apr;11(1):196-205 PMID: 29681821 PMCID: PMC5903146 04/24/2018    
  • Biological explanations for discordant noninvasive prenatal test results: Preliminary data and lessons learned. (Wilkins-Haug L, Zhang C, Cerveira E, Ryan M, Mil-Homens A, Zhu Q, Reddi H, Lee C, Bianchi DW) Prenat Diagn 2018 05;38(6):445-458 PMID: 29633279 PMCID: PMC6721610 SCOPUS ID: 2-s2.0-85048042954 04/11/2018       7 Citations
  • Clinical utility of a 377 gene custom next-generation sequencing epilepsy panel. (Bevilacqua J, Hesse A, Cormier B, Davey J, Patel D, Shankar K, Reddi HV) J Genet 2017 Sep;96(4):681-685 PMID: 28947717 SCOPUS ID: 2-s2.0-85026904598 09/28/2017       9 Citations
  • Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes. (VanderLaan PA, Rangachari D, Mockus SM, Spotlow V, Reddi HV, Malcolm J, Huberman MS, Joseph LJ, Kobayashi SS, Costa DB) Lung Cancer 2017 04;106:17-21 PMID: 28285689 PMCID: PMC5351777 SCOPUS ID: 2-s2.0-85012255059 03/14/2017       78 Citations
  • The first patient with tandem duplication of 6q14q16: Molecular and phenotypic characterization. (Sanmann JN, Casas KA, Bevilacqua J, Bishay DL, Clark T, Van Dyke AZ, Leiferman PC, Reddi HV, Starr LJ) Am J Med Genet A 2016 09;170(9):2416-20 PMID: 27338032 SCOPUS ID: 2-s2.0-84978264502 06/25/2016       2 Citations
  • Clinical management of amyloidosis: Genetic counseling as an important component of the treatment algorithm (Davey J, Bevilacqua J, Hesse A, Reddi HV) Amyloidosis: Risk Factors, Treatment Options and Clinical Aspects 1 January 2016:51-72 SCOPUS ID: 2-s2.0-85022056541 01/01/2016    
  • Mitochondrial Disease Sequence Data Resource (MSeqDR): a global grass-roots consortium to facilitate deposition, curation, annotation, and integrated analysis of genomic data for the mitochondrial disease clinical and research communities. (Falk MJ, Shen L, Gonzalez M, Leipzig J, Lott MT, Stassen AP, Diroma MA, Navarro-Gomez D, Yeske P, Bai R, Boles RG, Brilhante V, Ralph D, DaRe JT, Shelton R, Terry SF, Zhang Z, Copeland WC, van Oven M, Prokisch H, Wallace DC, Attimonelli M, Krotoski D, Zuchner S, Gai X, MSeqDR Consortium Participants, MSeqDR Consortium participants: Sherri Bale, Jirair Bedoyan, Doron Behar, Penelope Bonnen, Lisa Brooks, Claudia Calabrese, Sarah Calvo, Patrick Chinnery, John Christodoulou, Deanna Church,, Rosanna Clima, Bruce H. Cohen, Richard G. Cotton, IFM de Coo, Olga Derbenevoa, Johan T. den Dunnen, David Dimmock, Gregory Enns, Giuseppe Gasparre,, Amy Goldstein, Iris Gonzalez, Katrina Gwinn, Sihoun Hahn, Richard H. Haas, Hakon Hakonarson, Michio Hirano, Douglas Kerr, Dong Li, Maria Lvova, Finley Macrae, Donna Maglott, Elizabeth McCormick, Grant Mitchell, Vamsi K. Mootha, Yasushi Okazaki,, Aurora Pujol, Melissa Parisi, Juan Carlos Perin, Eric A. Pierce, Vincent Procaccio, Shamima Rahman, Honey Reddi, Heidi Rehm, Erin Riggs, Richard Rodenburg, Yaffa Rubinstein, Russell Saneto, Mariangela Santorsola, Curt Scharfe,, Claire Sheldon, Eric A. Shoubridge, Domenico Simone, Bert Smeets, Jan A. Smeitink, Christine Stanley, Anu Suomalainen, Mark Tarnopolsky, Isabelle Thiffault, David R. Thorburn, Johan Van Hove, Lynne Wolfe, and Lee-Jun Wong) Mol Genet Metab 2015 Mar;114(3):388-96 PMID: 25542617 PMCID: PMC4512182 SCOPUS ID: 2-s2.0-84924206735 12/30/2014       37 Citations
  • An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules. (McIver B, Castro MR, Morris JC, Bernet V, Smallridge R, Henry M, Kosok L, Reddi H) J Clin Endocrinol Metab 2014 Nov;99(11):4069-77 PMID: 24780044 SCOPUS ID: 2-s2.0-84910001603 05/02/2014       143 Citations
  • A compound T60A and V122I heterozygosity in the transthyretin gene causing early onset severe cardiac amyloidosis. (Liu YC, Reddi HV, Waheed S, Alapat D, Highsmith WE, Edmondson RD, Barlogie B, van Rhee F) Amyloid 2014 Jun;21(2):134-5 PMID: 24517438 SCOPUS ID: 2-s2.0-84900528066 02/13/2014    
  • Discordant results between biochemical and molecular transthyretin assays: lessons learned from a unique testing algorithm at the Mayo Clinic. (Reddi HV, Thomas BC, Willkomm KS, Ferber MJ, Rumilla KM, Raymond KM, O'Brien JF, Highsmith WE) J Genet 2013 Dec;92(3):599-604 PMID: 24371183 SCOPUS ID: 2-s2.0-84899504789 12/29/2013       1 Citation
  • RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma. (Smallridge RC, Chindris AM, Asmann YW, Casler JD, Serie DJ, Reddi HV, Cradic KW, Rivera M, Grebe SK, Necela BM, Eberhardt NL, Carr JM, McIver B, Copland JA, Thompson EA) J Clin Endocrinol Metab 2014 Feb;99(2):E338-47 PMID: 24297791 PMCID: PMC3913813 SCOPUS ID: 2-s2.0-84893772701 12/04/2013       35 Citations
  • Homozygosity for the V122I mutation in transthyretin is associated with earlier onset of cardiac amyloidosis in the African American population in the seventh decade of life. (Reddi HV, Jenkins S, Theis J, Thomas BC, Connors LH, Van Rhee F, Highsmith WE Jr) J Mol Diagn 2014 Jan;16(1):68-74 PMID: 24184229 SCOPUS ID: 2-s2.0-84890378018 11/05/2013       15 Citations
  • Redifferentiation and induction of tumor suppressors miR-122 and miR-375 by the PAX8/PPARγ fusion protein inhibits anaplastic thyroid cancer: a novel therapeutic strategy. (Reddi HV, Driscoll CB, Madde P, Milosevic D, Hurley RM, McDonough SJ, Hallanger-Johnson J, McIver B, Eberhardt NL) Cancer Gene Ther 2013 May;20(5):267-75 PMID: 23598436 SCOPUS ID: 2-s2.0-84878010790 04/20/2013       16 Citations
  • Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. (Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C) J Oncol Pract 2012 May;8(3 Suppl):e1s-5s PMID: 22942830 PMCID: PMC3348595 09/04/2012    
  • Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy. (Reddi HV, Madde P, McDonough SJ, Trujillo MA, Morris JC 3rd, Myers RM, Peng KW, Russell SJ, McIver B, Eberhardt NL) Cancer Gene Ther 2012 Sep;19(9):659-65 PMID: 22790962 SCOPUS ID: 2-s2.0-84865266991 07/14/2012       28 Citations
  • Foxo3a drives proliferation in anaplastic thyroid carcinoma through transcriptional regulation of cyclin A1: a paradigm shift that impacts current therapeutic strategies. (Marlow LA, von Roemeling CA, Cooper SJ, Zhang Y, Rohl SD, Arora S, Gonzales IM, Azorsa DO, Reddi HV, Tun HW, Döppler HR, Storz P, Smallridge RC, Copland JA) J Cell Sci 2012 Sep 15;125(Pt 18):4253-63 PMID: 22718346 PMCID: PMC3516436 SCOPUS ID: 2-s2.0-84872188837 06/22/2012       22 Citations
  • Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse Models. (Reddi HV, Madde P, Cohen YC, Bangio L, Breitbart E, Harats D, Bible KC, Eberhardt NL) Genes Cancer 2011 Oct;2(10):993-5 PMID: 22701765 PMCID: PMC3374632 06/16/2012    
  • Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. (Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C) Am J Manag Care 2012 May 01;18(5):e162-7 PMID: 22694109 06/15/2012    
  • Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers (Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C) American Journal of Managed Care May 2012;18(5) SCOPUS ID: 2-s2.0-84864401171 01/01/2012    
  • The Putative PAX8/PPARγ Fusion Oncoprotein Exhibits Partial Tumor Suppressor Activity through Up-Regulation of Micro-RNA-122 and Dominant-Negative PPARγ Activity. (Reddi HV, Madde P, Milosevic D, Hackbarth JS, Algeciras-Schimnich A, McIver B, Grebe SK, Eberhardt NL) Genes Cancer 2011 Jan;2(1):46-55 PMID: 21779480 PMCID: PMC3111009 07/23/2011    
  • Analysis of circulating microRNA: preanalytical and analytical challenges. (McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A) Clin Chem 2011 Jun;57(6):833-40 PMID: 21487102 SCOPUS ID: 2-s2.0-79957784825 04/14/2011       442 Citations
  • Unique cellular and mitochondrial defects mediate FK506-induced islet β-cell dysfunction. (Rostambeigi N, Lanza IR, Dzeja PP, Deeds MC, Irving BA, Reddi HV, Madde P, Zhang S, Asmann YW, Anderson JM, Schimke JM, Nair KS, Eberhardt NL, Kudva YC) Transplantation 2011 Mar 27;91(6):615-23 PMID: 21200364 PMCID: PMC3339767 SCOPUS ID: 2-s2.0-79952772991 01/05/2011       37 Citations
  • Expression of the PAX8/PPARγ Fusion Protein Is Associated with Decreased Neovascularization In Vivo: Impact on Tumorigenesis and Disease Prognosis. (Reddi HV, Madde P, Marlow LA, Copland JA, McIver B, Grebe SK, Eberhardt NL) Genes Cancer 2010 May;1(5):480-492 PMID: 20827445 PMCID: PMC2934914 09/10/2010    
  • Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis. (Algeciras-Schimnich A, Milosevic D, McIver B, Flynn H, Reddi HV, Eberhardt NL, Grebe SK) Clin Chem 2010 Mar;56(3):391-8 PMID: 20056739 PMCID: PMC3918957 SCOPUS ID: 2-s2.0-77649228521 01/09/2010       23 Citations
  • The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancer. (Eberhardt NL, Grebe SK, McIver B, Reddi HV) Mol Cell Endocrinol 2010 May 28;321(1):50-6 PMID: 19883731 PMCID: PMC2849860 SCOPUS ID: 2-s2.0-77950922596 11/04/2009       71 Citations
  • The Role of the PAX8/PPARgamma Fusion Oncogene in Thyroid Cancer. (Placzkowski KA, Reddi HV, Grebe SK, Eberhardt NL, McIver B) PPAR Res 2008;2008:672829 PMID: 18989374 PMCID: PMC2579323 11/08/2008    
  • ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice. (Reddi HV, Madde P, Reichert-Eberhardt AJ, Galanis EC, Copland JA, McIver B, Grebe SK, Eberhardt NL) Cancer Gene Ther 2008 Nov;15(11):750-7 PMID: 18583996 PMCID: PMC3180921 SCOPUS ID: 2-s2.0-53549107470 06/28/2008       8 Citations
  • Chromosomal rearrangements and the pathogenesis of differentiated thyroid cancer (Reddi HV, Algeciras-Schimnich A, McIver B, Eberhardt NL, Grebe SKG) Oncology Reviews September 2007;1(2):81-90 SCOPUS ID: 2-s2.0-84873574880 09/01/2007    
  • The notch regulator MAML1 interacts with p53 and functions as a coactivator. (Zhao Y, Katzman RB, Delmolino LM, Bhat I, Zhang Y, Gurumurthy CB, Germaniuk-Kurowska A, Reddi HV, Solomon A, Zeng MS, Kung A, Ma H, Gao Q, Dimri G, Stanculescu A, Miele L, Wu L, Griffin JD, Wazer DE, Band H, Band V) J Biol Chem 2007 Apr 20;282(16):11969-81 PMID: 17317671 SCOPUS ID: 2-s2.0-34249740225 02/24/2007       60 Citations
  • The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis. (Reddi HV, McIver B, Grebe SK, Eberhardt NL) Endocrinology 2007 Mar;148(3):932-5 PMID: 16946003 SCOPUS ID: 2-s2.0-33847057768 09/02/2006       35 Citations
  • Differential usage of carbohydrate co-receptors influences cellular tropism of Theiler's murine encephalomyelitis virus infection of the central nervous system. (Lipton HL, Kumar AS, Hertzler S, Reddi HV) Glycoconj J 2006 Feb;23(1-2):39-49 PMID: 16575521 SCOPUS ID: 2-s2.0-33645453614 04/01/2006       21 Citations
  • Heparan sulfate-independent infection attenuates high-neurovirulence GDVII virus-induced encephalitis. (Reddi HV, Kumar AS, Kung AY, Kallio PD, Schlitt BP, Lipton HL) J Virol 2004 Aug;78(16):8909-16 PMID: 15280499 PMCID: PMC479051 SCOPUS ID: 2-s2.0-3543114270 07/29/2004       15 Citations
  • Virus persistence in an animal model of multiple sclerosis requires virion attachment to sialic acid coreceptors. (Kumar AS, Reddi HV, Kung AY, Dal Canto M, Lipton HL) J Virol 2004 Aug;78(16):8860-7 PMID: 15280494 PMCID: PMC479047 SCOPUS ID: 2-s2.0-3543063967 07/29/2004       6 Citations
  • Susceptibility of peritoneal macrophages to infection by Theiler's virus. (Jelachich ML, Reddi HV, Trottier MD, Schlitt BP, Lipton HL) Virus Res 2004 Sep 01;104(2):123-7 PMID: 15246649 SCOPUS ID: 2-s2.0-3042828283 07/13/2004       5 Citations
  • Self-association of the hepatitis B virus X protein in the yeast two-hybrid system. (Reddi HV, Kumar V) Biochem Biophys Res Commun 2004 May 14;317(4):1017-22 PMID: 15094370 SCOPUS ID: 2-s2.0-1942516396 04/20/2004       2 Citations
  • A carboxy-terminal region of the hepatitis B virus X protein promotes DNA interaction of CREB and mimics the native protein for transactivation function. (Reddi H, Kumar R, Jain SK, Kumar V) Virus Genes 2003 May;26(3):227-38 PMID: 12876451 SCOPUS ID: 2-s2.0-0042315410 07/24/2003       12 Citations
  • Galactose is needed only for expression of co-receptors used by Theiler's murine encephalomyelitis virus as the virus does not directly bind galactose or use the UDP-galactose transporter as a receptor. (Reddi HV, Kallio P, Lipton HL) J Gen Virol 2003 Apr;84(Pt 4):845-849 PMID: 12655085 SCOPUS ID: 2-s2.0-0037383744 03/26/2003       3 Citations
  • Hepatocellular carcinoma in a hepatitis B 'x' transgenic mouse model: A sequential pathological evaluation. (Lakhtakia R, Kumar V, Reddi H, Mathur M, Dattagupta S, Panda SK) J Gastroenterol Hepatol 2003 Jan;18(1):80-91 PMID: 12519229 01/10/2003    
  • The calcium-binding protein of Entamoeba histolytica as a fusion partner for expression of peptides in Escherichia coli. (Reddi H, Bhattacharya A, Kumar V) Biotechnol Appl Biochem 2002 12;36(3):213-8 PMID: 12452805 SCOPUS ID: 2-s2.0-0346037317 11/28/2002       4 Citations
  • Heparan sulfate mediates infection of high-neurovirulence Theiler's viruses. (Reddi HV, Lipton HL) J Virol 2002 Aug;76(16):8400-7 PMID: 12134043 PMCID: PMC155119 SCOPUS ID: 2-s2.0-0036311560 07/23/2002       37 Citations
  • A monoclonal antibody against the X protein of hepatitis B virus: fine mapping of its epitope and application in a quantitative ELISA of the X protein in sera of hepatitis B patients. (Kumar V, Jayasuryan N, Reddi H, Sahal D, Panda SK) Hybridoma 1998 Apr;17(2):157-64 PMID: 9627056 SCOPUS ID: 2-s2.0-0031804912 06/17/1998       10 Citations
  • Last update: 03/01/2021